JP2023513156A5 - - Google Patents

Info

Publication number
JP2023513156A5
JP2023513156A5 JP2022547671A JP2022547671A JP2023513156A5 JP 2023513156 A5 JP2023513156 A5 JP 2023513156A5 JP 2022547671 A JP2022547671 A JP 2022547671A JP 2022547671 A JP2022547671 A JP 2022547671A JP 2023513156 A5 JP2023513156 A5 JP 2023513156A5
Authority
JP
Japan
Application number
JP2022547671A
Other languages
Japanese (ja)
Other versions
JP2023513156A (ja
JP7744914B2 (ja
JPWO2021158534A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/016194 external-priority patent/WO2021158534A1/en
Publication of JP2023513156A publication Critical patent/JP2023513156A/ja
Publication of JPWO2021158534A5 publication Critical patent/JPWO2021158534A5/ja
Publication of JP2023513156A5 publication Critical patent/JP2023513156A5/ja
Application granted granted Critical
Publication of JP7744914B2 publication Critical patent/JP7744914B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022547671A 2020-02-04 2021-02-02 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物 Active JP7744914B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062969917P 2020-02-04 2020-02-04
US62/969,917 2020-02-04
PCT/US2021/016194 WO2021158534A1 (en) 2020-02-04 2021-02-02 Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells

Publications (4)

Publication Number Publication Date
JP2023513156A JP2023513156A (ja) 2023-03-30
JPWO2021158534A5 JPWO2021158534A5 (https=) 2024-02-09
JP2023513156A5 true JP2023513156A5 (https=) 2024-02-09
JP7744914B2 JP7744914B2 (ja) 2025-09-26

Family

ID=77200468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022547671A Active JP7744914B2 (ja) 2020-02-04 2021-02-02 ハプテン標識細胞によりキメラ抗原受容体t細胞を刺激する方法およびそのための組成物

Country Status (9)

Country Link
US (1) US20230172981A1 (https=)
EP (1) EP4100026A4 (https=)
JP (1) JP7744914B2 (https=)
KR (1) KR20220164474A (https=)
CN (1) CN115397440A (https=)
AU (1) AU2021216554A1 (https=)
CA (1) CA3169804A1 (https=)
IL (1) IL295074A (https=)
WO (1) WO2021158534A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2934532B1 (en) 2012-12-20 2019-10-23 Purdue Research Foundation Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
JP7282521B2 (ja) 2016-04-08 2023-05-29 パーデュー・リサーチ・ファウンデイション Car t細胞療法のための方法および組成物
JP7178355B2 (ja) 2017-02-28 2022-11-25 エンドサイト・インコーポレイテッド Car t細胞療法のための組成物および方法
JP7549303B2 (ja) 2018-01-22 2024-09-11 エンドサイト・インコーポレイテッド Car t細胞の使用方法
SG11202007426XA (en) * 2018-02-06 2020-09-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
CN112105382A (zh) 2018-02-23 2020-12-18 恩多塞特公司 用于car t细胞疗法的顺序方法
AU2021217003A1 (en) 2020-02-04 2022-09-15 Seattle Children's Hospital (dba Seattle Children's Research Institute) Anti-dinitrophenol chimeric antigen receptors
WO2023178073A2 (en) * 2022-03-15 2023-09-21 Celledit Llc Use of antigen presenting cells to enhance car-t cell therapy
WO2024206913A2 (en) * 2023-03-31 2024-10-03 Northwestern University Compositions for antigen-specific immune cell activation
WO2024251866A1 (en) * 2023-06-06 2024-12-12 Danmarks Tekniske Universitet A synthetic cellular advanced signal adapter (scasa) system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020004052A1 (en) * 1990-05-08 2002-01-10 David Berd Composition comprising a tumor cell extract and method of using the composition
KR102376244B1 (ko) * 2014-12-24 2022-03-21 오토러스 리미티드 세포
WO2017075440A1 (en) * 2015-10-30 2017-05-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Targeted cancer therapy
CN115404196A (zh) 2016-07-13 2022-11-29 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
US10617720B2 (en) * 2016-10-20 2020-04-14 Miltenyi Biotech, GmbH Chimeric antigen receptor specific for tumor cells
EP3336107A1 (en) * 2016-12-15 2018-06-20 Miltenyi Biotec GmbH Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
US11590214B2 (en) * 2016-12-21 2023-02-28 Danmarks Tekniskte Universitet Antigen presenting scaffolds for immune-cell manipulation
CN110612119B (zh) * 2017-02-07 2024-10-29 西雅图儿童医院(Dba西雅图儿童研究所) 磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
WO2019060425A1 (en) 2017-09-19 2019-03-28 Massachusetts Institute Of Technology COMPOSITIONS FOR CHIMERIC ANTIGENIC RECEPTOR T CELL THERAPY AND USES THEREOF
MX2020004185A (es) * 2017-09-27 2021-01-08 Univ Southern California Nuevas plataformas para coestimulacion, nuevos diseños car y otras mejoras para terapia celular adoptiva.
SG11202007426XA (en) 2018-02-06 2020-09-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors
KR20210074274A (ko) * 2018-08-06 2021-06-21 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 합텐 표지된 세포로의 키메라 항원 수용체 t 세포의 자극을 위한 방법 및 조성물

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2023513156A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)